BrightGene Bio-Medical Technology Co. Ltd.SSE: 688166

Announcement on Preliminary Earnings Estimate for 2025

Feb 28, 2026 · Issued by BrightGene Bio-Medical Technology Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · Feb 28, 2026

On 6ix: 6ix.com/news/announcement-on-preliminary-earnings-estimate-for-2025-94

Announcement on Preliminary Earnings Estimate for 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

BrightGene Bio-Medical Technology Co. Ltd. on 6ix

Earlier from BrightGene Bio-Medical Technology

Announcement on Voluntary Disclosure of the Proposed Selection of Partial Products in the National Continuation Drug ProcurementFeb 12
Earnings Preannouncement for 2025Jan 31
Announcement on Not Redeeming ""BrightGene Convertible Bonds"" in AdvanceJan 6
Announcement on Postponing Investment Projects Financed by Raised FundsDec 31, 2025
Announcement on Interest Payment for "BrightGene Convertible Bonds" in 2025Dec 26, 2025

Later from BrightGene Bio-Medical Technology

Announcement on Outward Investment and Related Party TransactionsMar 11
2025 Annual ReportMar 20
Announcement on Convening the 2025 Annual Performance BriefingMar 25
BrightGene Announces Positive Topline Phase 1 Results of Oral BGM0504 in Obesity in China and the United StatesMar 25
Announcement on Resignation of the Directors and Senior Management MembersMar 31

All BrightGene Bio-Medical Technology news releases

Follow BrightGene Bio-Medical Technology into a list and get an email when it puts out news.

Follow BrightGene Bio-Medical Technology